Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2004 1
2005 2
2007 1
2008 2
2009 2
2010 4
2011 4
2012 5
2013 8
2014 5
2015 6
2016 7
2017 6
2018 7
2019 2
2020 7
2021 17
2022 26
2023 27
2024 23
2025 17
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

170 results

Results by year

Filters applied: . Clear all
Page 1
Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer.
Turner NC, Oliveira M, Howell SJ, Dalenc F, Cortes J, Gomez Moreno HL, Hu X, Jhaveri K, Krivorotko P, Loibl S, Morales Murillo S, Okera M, Park YH, Sohn J, Toi M, Tokunaga E, Yousef S, Zhukova L, de Bruin EC, Grinsted L, Schiavon G, Foxley A, Rugo HS; CAPItello-291 Study Group. Turner NC, et al. N Engl J Med. 2023 Jun 1;388(22):2058-2070. doi: 10.1056/NEJMoa2214131. N Engl J Med. 2023. PMID: 37256976 Free PMC article. Clinical Trial.
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer.
Cortés J, Kim SB, Chung WP, Im SA, Park YH, Hegg R, Kim MH, Tseng LM, Petry V, Chung CF, Iwata H, Hamilton E, Curigliano G, Xu B, Huang CS, Kim JH, Chiu JWY, Pedrini JL, Lee C, Liu Y, Cathcart J, Bako E, Verma S, Hurvitz SA; DESTINY-Breast03 Trial Investigators. Cortés J, et al. N Engl J Med. 2022 Mar 24;386(12):1143-1154. doi: 10.1056/NEJMoa2115022. N Engl J Med. 2022. PMID: 35320644 Clinical Trial.
Hereditary Cancer Syndromes: A Comprehensive Review with a Visual Tool.
Garutti M, Foffano L, Mazzeo R, Michelotti A, Da Ros L, Viel A, Miolo G, Zambelli A, Puglisi F. Garutti M, et al. Among authors: zambelli a. Genes (Basel). 2023 Apr 30;14(5):1025. doi: 10.3390/genes14051025. Genes (Basel). 2023. PMID: 37239385 Free PMC article. Review.
Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer: clinical trials, current impact, and future directions.
Gerosa R, De Sanctis R, Jacobs F, Benvenuti C, Gaudio M, Saltalamacchia G, Torrisi R, Masci G, Miggiano C, Agustoni F, Pedrazzoli P, Santoro A, Zambelli A. Gerosa R, et al. Among authors: zambelli a. Crit Rev Oncol Hematol. 2024 Apr;196:104324. doi: 10.1016/j.critrevonc.2024.104324. Epub 2024 Mar 8. Crit Rev Oncol Hematol. 2024. PMID: 38462150 Free article. Review.
The use of bone-modifying agents in early breast cancer: AIOM Guidelines update and perspectives.
Zambelli A, Gerosa R, Cinquini M, Di Maio M, Miglietta F, Arecco L, Biganzoli L, Bernardi D, Cortesi L, Del Mastro L, Dieci MV, Foglietta J, Fortunato L, Franco P, Mantellini P, Marchiò C, Meduri B, Micallo G, Musolino A, Salvetti A, Santini D, Lanzetta G, Cosentini D, Bertoldo F, Cazzato RL, Cellini F, Denaro V, Di Martino A, Fusco V, Greco C, Ibrahim T, Maccauro G, DeFeo G, Severi S, Gori S. Zambelli A, et al. Tumori. 2025 Oct;111(5):366-378. doi: 10.1177/03008916251367339. Epub 2025 Sep 15. Tumori. 2025. PMID: 40947910
The evolving landscape of hormone receptor-positive/HER2-negative metastatic breast cancer (EVOLVE): An Italian Delphi consensus report.
Miglietta F, Razeti MG, Caltavituro A, Dri A, Valenza C, Bianchini G, Biganzoli L, Botticelli A, Caruso M, Cinieri S, Criscitiello C, De Angelis C, De Laurentis M, Del Mastro L, De Placido S, Del Re M, Dieci MV, Fabi A, Generali D, Gennari A, Gerratana L, Giuliano M, Lambertini M, Malapelle U, Malorni L, Meattini I, Paris I, Pruneri G, Zamagni C, Zambelli A, Bidard FC, Guarneri V, Puglisi F, Curigliano G, Arpino G. Miglietta F, et al. Among authors: zambelli a. Crit Rev Oncol Hematol. 2025 Sep;213:104793. doi: 10.1016/j.critrevonc.2025.104793. Epub 2025 Jun 6. Crit Rev Oncol Hematol. 2025. PMID: 40484157 Free article. Review.
Unveiling the Potential of Cyclin-Dependent Kinases 4 and 6 Inhibitors Beyond Progression in Hormone Receptor Positive/Human Epidermal Growth Factor Negative Advanced Breast Cancer - A Clinical Review.
Benvenuti C, Grinda T, Rassy E, Dixon-Douglas J, Ribeiro JM, Zambelli A, Santoro A, Pistilli B. Benvenuti C, et al. Among authors: zambelli a. Curr Treat Options Oncol. 2024 Dec;25(12):1517-1537. doi: 10.1007/s11864-024-01259-4. Epub 2024 Nov 30. Curr Treat Options Oncol. 2024. PMID: 39614985 Free PMC article. Review.
Follow-up of early breast cancer in a public health system: A 2024 AIGOM consensus project.
Gori S, De Rose F, Ferro A, Fabi A, Angiolini C, Azzarello G, Cancian M, Cinquini M, Arecco L, Aristei C, Bernardi D, Biganzoli L, Cariello A, Cortesi L, Cretella E, Criscitiello C, De Giorgi U, Carmen De Santis M, Deledda G, Dessena M, Donati S, Dri A, Ferretti G, Foglietta J, Franceschini D, Franco P, Schirone A, Generali D, Gianni L, Giordani S, Grandi G, Cristina Leonardi M, Magno S, Malorni L, Mantoan C, Martorana F, Meattini I, Meduri B, Merlini L, Miglietta F, Modena A, Nicolis F, Palumbo I, Panizza P, Angela Rovera F, Salvini P, Santoro A, Taffurelli M, Toss A, Tralongo P, Turazza M, Valerio M, Verzè M, Vici P, Zamagni C, Curigliano G, Pappagallo G, Zambelli A; Italian Association of Multidisciplinary Oncology Groups (AIGOM). Gori S, et al. Among authors: zambelli a. Cancer Treat Rev. 2024 Dec;131:102832. doi: 10.1016/j.ctrv.2024.102832. Epub 2024 Oct 5. Cancer Treat Rev. 2024. PMID: 39437511 Free article. Review.
Parp-inhibitors in the therapeutic landscape of breast cancer patients with BRCA1 and BRCA2 pathogenic germline variants: An Italian consensus paper and critical review.
Zambelli A, Cortesi L, Gaudio M, Arpino G, Bianchini G, Caruso F, Cinieri S, Curigliano G, Del Mastro L, De Placido S, Fabi A, Fortunato L, Generali D, Gennari A, Gori S, Grandi G, Guarneri V, Klinger M, Livi L, Marchiò C, Palumbo I, Panizza P, Pravettoni G, Pruneri G, Puglisi F, Sapino A, Tinterri C, Turchetti D, De Laurentiis M. Zambelli A, et al. Cancer Treat Rev. 2024 Nov;130:102815. doi: 10.1016/j.ctrv.2024.102815. Epub 2024 Aug 21. Cancer Treat Rev. 2024. PMID: 39208751 Free article. Review.
170 results